Translational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, B15 2WB, UK.
Eye (Lond). 2024 Apr;38(6):1077-1083. doi: 10.1038/s41433-023-02845-w. Epub 2024 Jan 18.
Mild traumatic brain injury (mTBI) is common with many patients suffering disabling long-term sequelae, with visual symptoms frequently reported. There are no objective biomarkers of mTBI that are routinely used in clinical practice. Optical coherence tomography (OCT) has been used in mTBI research, as it enables visualisation of the neuroretina, allowing measurement of the retinal nerve fibre layer and ganglion cell layer. This systematic review aims to appraise the available literature and assess whether there are significant changes within the retinal nerve fibre layer and ganglion cell layer in subjects after mTBI. A systematic review was carried out in accordance with PRISMA guidelines and registered with PROSPERO (Number: CRD42022360498). Four databases were searched for relevant literature published from inception until 1 September 2022. Abstracts and full texts were screened by three independent reviewers. Initial screening of databases yielded 341 publications, of these, three fulfilled all the criteria for inclusion. All three studies showed thinning of the retinal nerve fibre layer, whereas there were no significant changes in the ganglion cell layer. This systematic review demonstrated that thinning of the retinal nerve fibre layer (but not of the ganglion cell layer) is associated with mTBI. It provides preliminary evidence for the use of the retinal nerve fibre layer as a potential biomarker of damage to the visual system in mTBI. Further prospective longitudinal studies ensuring uniform diagnosis and accurate phenotyping of mTBI are needed to understand the effects on the visual system and potential of OCT as a prognostic biomarker.
轻度创伤性脑损伤(mTBI)很常见,许多患者会出现长期致残的后遗症,常伴有视觉症状。目前,临床上尚无 mTBI 的客观生物标志物。光学相干断层扫描(OCT)已应用于 mTBI 研究,因为它可以可视化神经视网膜,从而可以测量视网膜神经纤维层和节细胞层。本系统评价旨在评估现有文献,并评估 mTBI 后患者的视网膜神经纤维层和节细胞层是否存在明显变化。本系统评价按照 PRISMA 指南进行,并在 PROSPERO(编号:CRD42022360498)中进行了注册。四个数据库搜索了从成立到 2022 年 9 月 1 日发表的相关文献。三位独立审查员筛选了摘要和全文。对数据库的初步筛选产生了 341 篇出版物,其中有 3 篇符合纳入标准。这三项研究均显示视网膜神经纤维层变薄,而节细胞层没有明显变化。本系统评价表明,视网膜神经纤维层变薄(而非节细胞层)与 mTBI 有关。它为将视网膜神经纤维层作为 mTBI 中视觉系统损伤的潜在生物标志物提供了初步证据。需要进一步进行前瞻性纵向研究,以确保 mTBI 的统一诊断和准确表型,从而了解对视觉系统的影响和 OCT 作为预后生物标志物的潜力。